Stockreport

Sangamo Therapeutics Third Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]

Sangamo Therapeutics, Inc.  (SGMO) 
Last sangamo therapeutics, inc. earnings: 2/28 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.sangamo.com
PDF Profit margin: 22% (up from net loss in 3Q 2023). The move to profitability was primarily driven by higher revenue. EPS: US$0.051 (up from US$0.59 loss in 3Q 2023). [Read more]